<DOC>
	<DOCNO>NCT02231593</DOCNO>
	<brief_summary>The purpose pilot study test SAGIT ( Signs symptoms - Associated comorbidities - GH concentration level - IGF-1 - Tumour ) . SAGIT Clinician-Reported Outcomes ( ClinROs ) tool develop describe patient acromegaly . This study determine potential use finalise operational version patient classification clinical practice study . In addition , study intend carry qualitative evaluation acceptability SAGIT practice endocrinologist term relevance , ease use , applicability usefulness tool practice .</brief_summary>
	<brief_title>SAGIT Classification Patients With Acromegaly Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Acromegaly</mesh_term>
	<criteria>Male female age 18 yearsold Patient diagnosis acromegaly presence pituitary adenoma , elevate IGF1 lack serum GH suppression oral glucose tolerance test ( OGTT ) Controlled/stable , active treatment na√Øve patient . Patient cognitive linguistic capacity understand information letter study Patient sign informed consent History noncompliance inability reliably receive treatment foreseeable future Gaps treatment great 1 month within 12 month prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>